HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Needham, M. Articles by Stockley, R. A. Search for Related Content PubMed PubMed Citation Articles by Needham, M. Articles by Stockley, R. A.

Exacerbations in ₁-antitrypsin deficiency

Lung Investigation Unit, Nuffield House, Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Birmingham, UK

CORRESPONDENCE: M. Needham, Respiratory Medicine, Queen Elizabeth Hospital, Birmingham B15 2TH, UK. Fax: 44 1216978257. E-mail: Michelle.Needham@uhb.nhs.uk

Keywords: ₁-antitrypsin deficiency, chronic obstructive pulmonary disease, health status, respiratory tract infections

Received: June 21, 2004
Accepted February 22, 2005

This study aimed to investigate the nature and effect of exacerbations in patients with ₁-antitrypsin deficiency and to assess the impact of exacerbations on health status. Furthermore, the relationship of exacerbations to changes in lung function and health status was investigated.

In total, 265 patients with severe deficiency (PiZ phenotype) were assessed over 12 months and a subgroup of 87 patients was studied for 3 yrs. Exacerbations were recorded and patients underwent full lung function testing and health status measurement.

Exacerbations occurred in 142 patients (54%) over 12 months, with a median duration of 14 days (interquartile range 7–21). Health status was significantly worse in patients with exacerbations, especially those with frequent exacerbations. Neither the presence nor the frequency of exacerbations showed a relationship to decline in forced expiratory volume in one second, but the number of exacerbations was weakly associated with decline in gas transfer of the lung for carbon monoxide. Despite lung function decline, health status did not change significantly over 3 yrs.

In conclusion, exacerbations occur commonly in patients with ₁-antitrypsin deficiency and are associated with worse health status. Exacerbations were associated with a decline in the gas transfer of the lung for carbon monoxide over time, but show no relationship to changes in forced expiratory volume in one second. Despite lung function decline, patients do not show a progressive loss in health status.

This article has been cited by other articles:

				G. Tirado-Conde, B. Lara, and M. Miravitlles Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency Therapeutic Advances in Respiratory Disease, February 1, 2008; 2(1): 13 - 21. [Abstract] [PDF]

				M. A. Campos, S. Alazemi, G. Zhang, R. A. Sandhaus, and A. Wanner Influenza Vaccination in Subjects With {alpha}1-Antitrypsin Deficiency Chest, January 1, 2008; 133(1): 49 - 55. [Abstract] [Full Text] [PDF]

				K. Vijayasaratha and R. A. Stockley Reported and Unreported Exacerbations of COPD: Analysis by Diary Cards Chest, January 1, 2008; 133(1): 34 - 41. [Abstract] [Full Text] [PDF]